DIMENSIONAL FUND ADVISORS LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 354204
AUSTIN, TX
Position in TEVA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$86,281,570
-$831,281 QoQ
Shares Held
2,864,594
+2.6% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83%
Shared 9%
None 8%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $3,107,808,414 across 44 Drug Manufacturers - Specialty & Generic names. TEVA ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
24,527,135 | $586,934,337 | |
| 2 | VTRS |
Viatris Inc
|
38,310,693 | $517,577,461 | |
| 3 | ZTS |
Zoetis Inc.
|
2,771,447 | $327,612,748 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
512,739 | $304,043,970 | |
| 5 | ALKS |
Alkermes plc.
|
4,522,378 | $159,911,284 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
2,672,777 | $158,415,490 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,307,030 | $119,250,378 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,379,570 | $104,640,383 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $86,281,570 | 2,864,594 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $87,112,851 | 2,791,184 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,413,185 | 2,792,732 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $46,516,154 | 2,775,427 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $42,250,099 | 2,748,868 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $57,562,813 | 2,611,743 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $41,408,624 | 2,297,926 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $23,833,939 | 1,466,704 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $16,816,479 | 1,191,813 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $11,884,341 | 1,138,347 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $12,202,278 | 1,196,302 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,431,981 | 1,783,796 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $30,752,535 | 3,474,863 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $32,572,762 | 3,571,575 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $38,173,084 | 4,730,246 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $42,197,711 | 5,611,398 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $56,399,645 | 6,006,352 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $42,243,089 | 5,273,794 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $34,387,089 | 3,530,502 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $32,249,457 | 3,257,521 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $34,824,708 | 3,017,739 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,446,121 | 2,326,023 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $20,591,625 | 2,285,419 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $31,130,500 | 2,524,777 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $25,802,144 | 2,873,290 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||